Sharekhan

Advanced Enzyme Technologies Ltd

Thu 13/03/2025,15:59:6 | NSE : ADVENZYMES

₹ 267.00-0.60 (-0.22%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 268.05

Previous Close

₹ 267.60

Volume

277055

Mkt Cap ( Rs. Cr)

₹2987.21

High

₹ 278.40

Low

₹ 265.35

52 Week High

₹ 571.00

52 Week Low

₹ 257.90

Book Value Per Share

₹ 119.92

Dividend Yield

0.41

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Advanced Enzyme Technologies Ltd

Your Vote -

Buy

94.70%

Hold

0.59%

Sell

4.72%

94.70%

1018 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

267.00

150

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

150

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Advanced Enzyme Technologies Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Mar 2025, 4:37PM Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Mar 2025, 4:34PM Intimation of Analyst / Institutional Investor Meeting with Raintree Family Office
  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Mar 2025, 11:38AM Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet
  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Mar 2025, 2:45PM Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    10 Mar 2025, 2:38PM Intimation of Analyst / Institutional Investor Meeting with Motilal Oswal Financial Services Ltd / Royce Investment Partners under the Securities and
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 Feb 2025, 6:56PM Intimation of Analyst / Institutional Investor Meeting with Fidelity International and Dhamma Capital
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 Feb 2025, 6:53PM Intimation of Analyst / Institutional Investor Meeting with CapGrow Capital & ICICI Prudential Asset Management
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 Feb 2025, 6:50PM Intimation of Analyst / Institutional Investor Meeting with Grandeur Peak Advisors LLP, USA & Ethos Investment Management, USA
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 Feb 2025, 6:47PM Intimation of Analyst / Institutional Investor Meeting with Securities Investment Management Pvt Ltd (SIMPL)
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 Feb 2025, 6:44PM Intimation of Analyst / Institutional Investor Meeting with NT Asset Management, Thailand
  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    27 Feb 2025, 6:43PM Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet
  • Advanced Enzyme Tech - Credit Rating

    17 Feb 2025, 6:36PM Advanced Enzyme Technologies Limited has informed the Exchange about Credit Rating
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Credit Rating

    17 Feb 2025, 6:34PM In terms of Regulation 30 and Schedule III to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations
  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Feb 2025, 2:37PM Advanced Enzyme Technologies Limited has informed the Exchange about Transcript
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    17 Feb 2025, 2:32PM In futherance to our intimation letter dated February 03, 2025, please find enclosed the Transcript of the Conference Call held on Wednesday, February
  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Feb 2025, 6:19PM Advanced Enzyme Technologies Limited has informed the Exchange about Link of Recording
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    12 Feb 2025, 6:17PM Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as am
  • Advanced Enzyme Tech - Copy of Newspaper Publication

    10 Feb 2025, 3:44PM Advanced Enzyme Technologies Limited has informed the Exchange about Copy of Newspaper Publication
  • Advanced Enzyme Tech - Integrated Filing- Financial

    8 Feb 2025, 11:39PM Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Investor Presentation

    8 Feb 2025, 9:20PM Earning Presentation- Third Quarter FY2024-25
  • Advanced Enzyme Tech - Investor Presentation

    8 Feb 2025, 9:15PM Advanced Enzyme Technologies Limited has informed the Exchange about Investor Presentation
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    8 Feb 2025, 8:59PM Press Release- Third Quarter FY 2024-2025
  • Advanced Enzyme Tech - Press Release

    8 Feb 2025, 8:55PM Advanced Enzyme Technologies Limited has informed the Exchange regarding a press release dated February 08, 2025, titled ""Press Release"".
  • Advanced Enzyme Tech - Outcome of Board Meeting

    8 Feb 2025, 12:49PM Advanced Enzyme Technologies Limited has informed the Exchange regarding Board meeting held on February 08, 2025.
  • Advanced Enzyme Tech - Financial Result Updates

    8 Feb 2025, 12:41PM Advanced Enzyme Technologies Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
  • Advanced Enzyme Tech Q3 net profit down 20.61% at Rs 15.18 cr

    8 Feb 2025, 1:01PM The company reported standalone net profit of Rs 15.18 crore for the quarter ended December 31, 2024 as compared to Rs 19.12 crore in the same period
  • Advanced Enzyme Tech - Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months

    8 Feb 2025, 12:51PM Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) of the Company for th
  • Advanced Enzyme Tech - Board Meeting Outcome for Outcome Of Board Meeting Held On February 08, 2025

    8 Feb 2025, 12:39PM With reference to the notice of Board Meeting dated February 01, 2025, we hereby inform that the Board of Directors at its Meeting held on February 08
  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Feb 2025, 6:35PM Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Feb 2025, 6:31PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish t
  • Advanced Enzyme Tech - Board Meeting Intimation

    1 Feb 2025, 5:32PM ADVANCED ENZYME TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 08-Feb-2025 to inter-alia consider and approve the Un
  • Advanced Enzyme Tech has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    14 Jan 2025, 11:40AM As of December 2024, 42.93% is owned by Promoters and 57.07% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 1.97% and Fo
  • Advanced Enzyme Tech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jan 2025, 6:31PM Advanced Enzyme Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Advanced Enzyme Tech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jan 2025, 6:28PM Certificate under Regulation 74(5) of SEBI(DP) Regulations, 2018
  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Jan 2025, 6:44PM Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Jan 2025, 6:31PM Intimation of Analyst / Institutional Investor Meeting with NV Alpha Fund Management
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Jan 2025, 6:24PM Intimation of Analyst / Institutional Investor Meeting with Equitree Capital
  • Advanced Enzyme Tech - Trading Window

    27 Dec 2024, 1:01PM Advanced Enzyme Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)
  • Advanced Enzyme Tech - Trading Window-XBRL

    27 Dec 2024, 1:00PM Advanced Enzyme Technologies Limited has informed the Exchange about Closure of Trading Window
  • Advanced Enzyme Tech - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    19 Dec 2024, 4:26PM Advanced Enzyme Technologies Limited has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
  • Advanced Enzyme Tech - General Updates

    19 Dec 2024, 3:56PM Advanced Enzyme Technologies Limited has informed the Exchange about General Updates
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    19 Dec 2024, 3:48PM The Company has today completed the further Investment in Advanced Enzymes Europe B.V., Wholly Owned Subsidiary (AEE) through an acquisition of new is
  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Dec 2024, 4:17PM Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    16 Dec 2024, 4:12PM Analyst / Institutional Meet on December 19, 2024 with Tata Mutual Fund
  • Advanced Enzymes announces positive clinical breakthrough

    13 Sep 2021 , 12:08PM Advanced Enzymes announces positive clinical breakthrough in the randomised controlled trials of systemic enzymes & probiotics to resolve 'long COVID’ fatigue symptoms
  • Advanced Enzymes

    19 Oct 2020 , 10:57AM Advanced Enzymes: CRISIL has upgraded long term credit rating of Advanced Enzymes to “CRISIL A+/Stable” from “CRISIL A/Stable” earlier and has reaffirmed short term credit rating at CRISIL A1.
  • Advanced Enzyme hits 52-week high

    17 Sep 2020 , 12:21PM Advanced Enzyme rises by 5% to Rs. 243.30 in weak market

Key fundamentals

Evaluate the intrinsic value of Advanced Enzyme Technologies Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 580.471 525.339 480.528 435.763 379.107
Liabilities 580.471 525.339 480.528 435.763 379.107
Equity 22.365 22.365 22.36 22.346 22.336
Gross Profit 105.186 74.888 72.648 100.621 76.766
Net Profit 108.123 55.527 54.511 71.012 57.955
Cash From Operating Activities 55.81 50.296 37.102 84.192 45.976
NPM(%) 29.58 17.82 19.98 25.05 23.42
Revenue 365.469 311.529 272.798 283.473 247.354
Expenses 260.283 236.641 200.15 182.852 170.588
ROE(%) 8.05 4.13 4.06 5.29 4.31

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
18 Jul 2024 1.1 55 0.41 398.65
04 Aug 2023 1 50 0.41 284.65
11 Aug 2022 1 50 0.41 277.85
31 Aug 2021 0.9 45 0.41 427.85
09 Jul 2020 0.6 30 0.41 149.9
01 Aug 2019 0.6 30 0.41 200.85
06 Sep 2018 0.5 25 0.41 221.4
04 Sep 2017 0.4 20 0.41 362.4

Peers

Other companies within the same industry or sector that are comparable to Advanced Enzyme Technologies Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sameera Agro And Infra Ltd 56.60 -3.33 7.72 317.81 90.02 0.00
Shreeoswal Seeds and Chemicals Ltd 15.28 -0.39 0.00 2440.88 -22.75 0.00
GRM Overseas Ltd 273.21 1.01 26.47 1601.10 498.18 0.00
Jain Irrigation Systems Ltd 55.90 -0.80 0.00 18326.19 33.67 0.00

Company Info

The Company was incorporated, as a private limited company on March 15, 1989 under the provisions of the Companies Act, 1956 as Advanced Biochemicals Private Limited in Maharashtra. Pursuant to a special resolution passed by the shareholders of the Company at the extra-ordinary general meeting held on April 21, 1992, the Company was converted into a public limited company and consequently the name of the Company was changed to Advanced Biochemicals Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra on May 28, 1992. Pursuant to a special resolution passed by the shareholders of the Company at the extraordinary general meeting held on August 8, 2005, the name of the Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra, Mumbai on August 19, 2005.  Major events in the History of the Company 1989 - Incorporation as Advanced Biochemicals Private Limited.  1992 - Conversion from private company into a public company and renamed as Advanced Biochemicals Limited. 1994 - Commissioning of the first fermentation facility at Sinnar, Maharashtra  2001 - Recognition of in-house R&D centers of the Company at Thane and Sinnar by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India.  2005 - Change of name of the Company from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited.  2011 - Takeover of Cal-India Foods International (Specialty Enzymes and Biotechnologies) by the Company giving us direct presence in USA.  2012 - Kotak India Venture Fund I, Kotak Employees Investment Trust and Kotak India Venture (Offshore) Fund made an investment in the Company.  2012 - Takeover of AST Enzymes by the Company for consolidating the presence in USA. Awards and accreditations received by the Company  2010 - The Company won the "Emerging India Awards" for 2010 in the Life Science -Pharmaceuticals & Chemicals segment organized by ICICI Business Banking and CNBC TV18.2010 - The Company won the Bio Excellence Award in the Industrial Biotech category for 2010 instituted by Department of Information Technology, Biotechnology and Science and Technology, Government of Karnataka.2012 - The Company was awarded as the 1st runner-up for the Most Innovative Exporter - Dun & Bradstreet for the year 2012.  2013 - The Company was one of the Recipients of the fastest growing mid-sized business award organized by Inc. India.  2014 - The Company received the Bio Excellence Award in the Industrial Biotech category for year 2014 instituted by Department of Information Technology, Biotechnology and Science and Technology,Government of Karnataka. 2016 -Advanced Enzyme Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. - "Advanced Enzymes acquires 70% stake in API maker JC Biotech". - Advanced Enzyme Technologies has been awarded by ABP News for being "The Best Nutraceutical Company of the Year". 2017 -The Company has been awarded for 'BEST IPO' at IR Society Awards 2017. -Acquired 100% stake in a German based company evoxx technologies GmbH. 2018 -Acquired 100% stake in SciTech Specialties Private Limited. 2023 -Advanced Enzyme Technologies Limited has informed the Exchange regarding 'Update on acquisition of 50% stake in Saiganesh Enzytech Solutions Private Limited;and an additional 4.83% of JC Biotech Private Limited. 2024 -Advanced Enzyme Technologies Limited has informed the acquisition of additional stake of 5.89% in JC Biotech Private Limited.

The Company was incorporated, as a private limited company on March 15, 1989 under the provisions of the Companies Act, 1956 as Advanced Biochemicals Private Limited in Maharashtra. Pursuant to a special resolution passed by the shareholders of the Company at the extra-ordinary general meeting held on April 21, 1992, the Company was converted into a public limited company and consequently the name of the Company was changed to Advanced Biochemicals Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra on May 28, 1992. Pursuant to a special resolution passed by the shareholders of the Company at the extraordinary general meeting held on August 8, 2005, the name of the Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra, Mumbai on August 19, 2005.  Major events in the History of the Company 1989 - Incorporation as Advanced Biochemicals Private Limited.  1992 - Conversion from private company into a public company and renamed as Advanced Biochemicals Limited. 1994 - Commissioning of the first fermentation facility at Sinnar, Maharashtra  2001 - Recognition of in-house R&D centers of the Company at Thane and Sinnar by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India.  2005 - Change of name of the Company from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited.  2011 - Takeover of Cal-India Foods International (Specialty Enzymes and Biotechnologies) by the Company giving us direct presence in USA.  2012 - Kotak India Venture Fund I, Kotak Employees Investment Trust and Kotak India Venture (Offshore) Fund made an investment in the Company.  2012 - Takeover of AST Enzymes by the Company for consolidating the presence in USA. Awards and accreditations received by the Company  2010 - The Company won the "Emerging India Awards" for 2010 in the Life Science -Pharmaceuticals & Chemicals segment organized by ICICI Business Banking and CNBC TV18.2010 - The Company won the Bio Excellence Award in the Industrial Biotech category for 2010 instituted by Department of Information Technology, Biotechnology and Science and Technology, Government of Karnataka.2012 - The Company was awarded as the 1st runner-up for the Most Innovative Exporter - Dun & Bradstreet for the year 2012.  2013 - The Company was one of the Recipients of the fastest growing mid-sized business award organized by Inc. India.  2014 - The Company received the Bio Excellence Award in the Industrial Biotech category for year 2014 instituted by Department of Information Technology, Biotechnology and Science and Technology,Government of Karnataka. 2016 -Advanced Enzyme Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. - "Advanced Enzymes acquires 70% stake in API maker JC Biotech". - Advanced Enzyme Technologies has been awarded by ABP News for being "The Best Nutraceutical Company of the Year". 2017 -The Company has been awarded for 'BEST IPO' at IR Society Awards 2017. -Acquired 100% stake in a German based company evoxx technologies GmbH. 2018 -Acquired 100% stake in SciTech Specialties Private Limited. 2023 -Advanced Enzyme Technologies Limited has informed the Exchange regarding 'Update on acquisition of 50% stake in Saiganesh Enzytech Solutions Private Limited;and an additional 4.83% of JC Biotech Private Limited. 2024 -Advanced Enzyme Technologies Limited has informed the acquisition of additional stake of 5.89% in JC Biotech Private Limited.

Read More

Parent Organisation

Advanced Enzyme Technologies Ltd.

Founded

15/03/1989

Managing Director

NSE Symbol

ADVENZYMESEQ

FAQ

The current price of Advanced Enzyme Technologies Ltd is ₹ 267.00.

The 52-week high for Advanced Enzyme Technologies Ltd is ₹ 278.40 and the 52-week low is ₹ 265.35.

The market capitalization of Advanced Enzyme Technologies Ltd is currently ₹ 2987.21. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Advanced Enzyme Technologies Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Advanced Enzyme Technologies Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Advanced Enzyme Technologies Ltd shares.

The CEO of Advanced Enzyme Technologies Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT